Colgate-Palmolive Company (CL) Stake Reduced by Wagner Bowman Management Corp
Wagner Bowman Management Corp lowered its position in Colgate-Palmolive Company (NYSE:CL) by 1.2% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 26,403 shares of the company’s stock after selling 329 shares during the period. Wagner Bowman Management Corp’s holdings in Colgate-Palmolive were worth $1,957,000 as of its most recent SEC filing.
Other institutional investors have also recently modified their holdings of the company. American Beacon Advisors Inc. purchased a new position in shares of Colgate-Palmolive during the first quarter worth $102,000. Proficio Capital Partners LLC increased its position in shares of Colgate-Palmolive by 16.9% in the first quarter. Proficio Capital Partners LLC now owns 1,432 shares of the company’s stock worth $107,000 after buying an additional 207 shares during the last quarter. Harbour Capital Advisors LLC purchased a new position in shares of Colgate-Palmolive during the first quarter worth $121,000. AlphaMark Advisors LLC increased its position in shares of Colgate-Palmolive by 452.1% in the first quarter. AlphaMark Advisors LLC now owns 1,673 shares of the company’s stock worth $122,000 after buying an additional 1,370 shares during the last quarter. Finally, Mascoma Wealth Management LLC purchased a new position in shares of Colgate-Palmolive during the second quarter worth $131,000. Institutional investors and hedge funds own 73.69% of the company’s stock.
Shares of Colgate-Palmolive Company (CL) traded up 0.97% during midday trading on Friday, hitting $71.47. 771,640 shares of the stock were exchanged. The firm has a market capitalization of $62.95 billion, a price-to-earnings ratio of 26.56 and a beta of 0.80. The stock’s 50-day moving average price is $72.05 and its 200-day moving average price is $73.08. Colgate-Palmolive Company has a 1-year low of $63.43 and a 1-year high of $77.27.
Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings data on Friday, July 21st. The company reported $0.72 EPS for the quarter, meeting analysts’ consensus estimates of $0.72. The company had revenue of $3.83 billion during the quarter, compared to analysts’ expectations of $3.89 billion. Colgate-Palmolive had a return on equity of 3,121.95% and a net margin of 15.83%. Colgate-Palmolive’s revenue for the quarter was down .5% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.70 earnings per share. On average, analysts forecast that Colgate-Palmolive Company will post $2.89 EPS for the current year.
The company also recently disclosed a quarterly dividend, which was paid on Tuesday, August 15th. Investors of record on Tuesday, July 18th were given a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a yield of 2.26%. The ex-dividend date of this dividend was Friday, July 14th. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 59.48%.
A number of equities analysts recently weighed in on CL shares. Bank of America Corporation boosted their target price on shares of Colgate-Palmolive from $78.00 to $80.00 and gave the stock a “buy” rating in a report on Wednesday, May 31st. Zacks Investment Research upgraded shares of Colgate-Palmolive from a “hold” rating to a “buy” rating and set a $83.00 target price on the stock in a report on Tuesday, July 4th. Jefferies Group LLC boosted their target price on shares of Colgate-Palmolive from $76.00 to $77.00 and gave the stock a “hold” rating in a report on Thursday, July 6th. Royal Bank Of Canada restated a “hold” rating and set a $74.00 target price on shares of Colgate-Palmolive in a report on Friday, June 30th. Finally, Vetr cut shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and set a $76.67 price objective for the company. in a research report on Wednesday, May 17th. Two investment analysts have rated the stock with a sell rating, twelve have issued a hold rating and two have given a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and a consensus price target of $75.82.
In other Colgate-Palmolive news, insider Patricia Verduin sold 3,833 shares of the company’s stock in a transaction dated Thursday, June 15th. The stock was sold at an average price of $75.67, for a total value of $290,043.11. Following the completion of the sale, the insider now owns 53,022 shares in the company, valued at $4,012,174.74. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, COO Justin Skala sold 74,374 shares of the company’s stock in a transaction dated Thursday, July 27th. The stock was sold at an average price of $72.51, for a total value of $5,392,858.74. Following the completion of the sale, the chief operating officer now owns 97,177 shares of the company’s stock, valued at approximately $7,046,304.27. The disclosure for this sale can be found here. In the last quarter, insiders have sold 221,802 shares of company stock valued at $15,983,976. 1.02% of the stock is owned by company insiders.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Receive News & Stock Ratings for Colgate-Palmolive Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive Company and related stocks with our FREE daily email newsletter.